| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827545 | Transplantation Proceedings | 2017 | 5 Pages |
Abstract
Up to 35% of kidney transplant recipients admitted for acute infection present with high tacrolimus TLs, requiring a dose reduction. How acute infection precisely affects metabolism and bioavailability of tacrolimus remains to be investigated.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
C. Percy, Z. Hassoun, M. Mourad, M. De Meyer, C. Beguin, M. Jadoul, E. Goffin, P. Wallemacq, N. Kanaan,